Main > CARDIOLOGY (**) > DE. C. HF & reduced LVEF after MI

---

DE. C. HF & reduced LVEF after MI's subsections
Company
Company Web-Site
oligonucleotide-based miR-132 Inh.
Patents
Status: Phase II
TM
UpDate: 2023. 03.24

DE. C. HF & reduced LVEF after MI's products
This section has no products